Dublin, Sept. 11, 2026 (GLOBE NEWSWIRE) -- "A Practical Approach to Veterinary Vaccine Development and Registration in the EU (Mar 9th - Mar 10th, 2027)" has been added to ResearchAndMarkets.com's offering.
Professionals involved in veterinary vaccine development and market approval will have a focused opportunity to strengthen their understanding of the European regulatory pathway during A Practical Approach to Veterinary Vaccine Development and Registration in the EU, taking place online on March 9–10, 2027, from 08:30 to 15:30 GMT. The two-day training course addresses the complex requirements involved in developing veterinary vaccines and successfully achieving market authorisation in the EU.
Organised by IPI Academy, the course is designed around practical advice and guidance, taking participants step by step through the development and registration process. With demand for biologics in veterinary medicine increasing, the programme focuses on the regulatory, quality, safety and efficacy considerations that must be addressed when bringing veterinary vaccines toward market approval.
The course includes a practical guide to the EU regulatory framework for veterinary vaccines, procedures aimed at promoting vaccine availability, and detailed consideration of marketing authorisation dossier requirements covering quality, safety and efficacy. Participants will also explore the use of the Summary of Product Characteristics (SPC) as a development tool, vaccine development planning, regulatory advice for novel vaccines, dossier preparation and submission, and European licensing procedures and regulatory strategy.
A dedicated workshop will provide an opportunity to apply the requirements in practice, followed by group reporting and Q&A. Discussion time throughout the two-day programme is also intended to facilitate engagement with expert faculty and fellow professionals. The course carries 12 CPD hours.
Why You Should Attend
- Understand the EU regulatory framework for veterinary vaccines and the procedures intended to promote vaccine availability.
- Examine marketing authorisation dossier requirements across quality, safety and efficacy.
- Apply development principles in practice through the vaccine development planning workshop, group report-back and Q&A.
- Explore regulatory strategy for novel vaccines, including when and how to seek regulatory advice.
- Strengthen registration planning through sessions on dossier preparation, submission and European licensing procedures.
Featured Speakers
- Mel Munro; Consultant in veterinary medicinal product development and registration with more than 20 years' experience, providing regulatory advice across biologicals development and Marketing Authorisation.
- Michael Fontaine, PhD;Molecular bacteriology specialist with more than 25 years' experience in discovery and development of biological products for the animal health industry, including senior roles at Benchmark Animal Health and Virbac.
The programme is intended for professionals working with veterinary vaccines from development through market approval, including new entrants to registration departments, veterinary medicinal product manufacturers, registration managers, research and development departments, academics interested in commercialisation opportunities, and personnel from micro, small and medium-sized enterprises (SMEs).
For more information about this training visit https://www.researchandmarkets.com/r/okwxuv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
